Tecon Biology’s mixed Q3 results: Profit tumbles as revenue grows, acquires livestock firm

Tecon Biology (SZSE:002100) reported a 6.49% decrease in Q3 2025 revenue to 4,763,645,003.62 yuan, while year-to-date revenue saw a 4.00% increase to 13,610,370,203.12 yuan. Net profit attributable to shareholders for Q3 declined significantly by 74.58% to 73,460,235.54 yuan, with year-to-date net profit also falling by 27.20% to 411,749,486.05 yuan. The company's operating cash flow net amount, however, improved by 9.56% year-to-date, reaching 2,350,579,030.51 yuan.

The company's board of directors approved the Q3 2025 report on October 29, 2025. Key balance sheet changes included a 2267.96% increase in trading financial assets, attributed to an increase in structured deposit business. Short-term borrowings decreased by 31.19% due to loan repayments, and inventory decreased by 33.22% as stored protein, fat, and corn from the previous acquisition season were largely sold off.

In a strategic move, Tecon Biology signed a framework agreement on August 25, 2025, to acquire a 51% equity stake in Xinjiang Qiangdu Livestock Technology Co., Ltd. This acquisition is expected to give Tecon Biology a controlling interest in Xinjiang Qiangdu Livestock.